Evidence map›Paper›PMID 30962989›Full record

ArticleJournal of thoracic disease2019

Pathological discrepancies in the diagnosis of thymic epithelial tumors: the Tallinn-Lyon experience.

Kersti Oselin, Nicolas Girard, Katrin Lepik, Aidi Adamson-Raieste, Tõnu Vanakesa, Ingemar Almre, Tiina Leismann, Lara Chalabreysse

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kersti OselinDepartment of Chemotherapy, North Estonia Medical Centre, Tallinn 13419, Estonia.
Nicolas GirardUniversité Lyon 1, Université de Lyon, Hospices Civils de Lyon, Lyon (Bron) 69677, France.
Katrin LepikDepartment of Pathology, North Estonia Medical Centre, Tallinn 13419, Estonia.
Aidi Adamson-RaiesteDepartment of Radiotherapy, North Estonia Medical Centre, Tallinn 13419, Estonia.
Tõnu VanakesaDepartment of Thoracic Surgery, North Estonia Medical Centre, Tallinn 13419, Estonia.
Ingemar AlmreDepartment of Thoracic Surgery, North Estonia Medical Centre, Tallinn 13419, Estonia.
Tiina LeismannDepartment of Pathology, North Estonia Medical Centre, Tallinn 13419, Estonia.
Lara ChalabreysseUniversité Lyon 1, Université de Lyon, Hospices Civils de Lyon, Lyon (Bron) 69677, France.
North Estonia Medical Centre · EEHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThymic epithelial tumors are rare thoracic tumors for which pathological diagnosis is challenging due to the definition of multiple subtypes, tumor heterogeneity, and variations in interobserver reproducibility. In this study, we aimed at analyzing the quality of pathological reporting in line with the consistency between initial diagnosis and final diagnosis after expert review through a collaboration between the largest thoracic oncology center in Estonia, and one expert center in France.

methodsHospital electronic database and pathology databases from the Tallinn North Estonia Medical Centre were searched for thymic and mediastinal tumors from 2010 to 2017. Pathology specimens were referred to the Pathology Department of the Lyon University hospital. Overall, 55 tissue specimens from 49 patients were included.

resultsFrom pathology reports, tumor size, diagnosis, and invasion had been mentioned in ≥80% of cases, while resection status and staging were assessed in only 48% and 17% of cases, respectively. The initial diagnosis was consistent with that of the review in 60% of cases. Diagnostic concordance for thymoma subtypes was low (Cohen's kappa 0.34, 95% CI: 0.16-0.52). Overall, a major change in the management of 8 (16%) patients had to be made after pathological review: 3 patients had a normal thymus according to the reference centre, while thymoma B1 or B2 had been diagnosed locally; 5 additional patients had a final diagnosis of non-thymic tumor.

conclusionsImplementing structured pathology reports may help to decrease discrepancies in the diagnosis of thymic epithelial tumors. The development of expert networks is an opportunity to improve diagnosis and patient care, particularly in regard to rare cancers.

Indexed as

diagnostic discrepancypathologyThymic epithelial tumors

Identifiers

PMID30962989
PMCPMC6409262
OpenAlexW2912969366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.